A detailed history of Rhumbline Advisers transactions in Angiodynamics Inc stock. As of the latest transaction made, Rhumbline Advisers holds 62,269 shares of ANGO stock, worth $445,223. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,269
Previous 61,777 0.8%
Holding current value
$445,223
Previous $362,000 3.87%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$5.65 - $7.03 $2,779 - $3,458
492 Added 0.8%
62,269 $376,000
Q1 2024

May 09, 2024

SELL
$5.27 - $8.03 $5,733 - $8,736
-1,088 Reduced 1.73%
61,777 $362,000
Q4 2023

Feb 08, 2024

SELL
$6.17 - $8.04 $4,732 - $6,166
-767 Reduced 1.21%
62,865 $492,000
Q3 2023

Nov 09, 2023

SELL
$7.02 - $10.32 $467,925 - $687,889
-66,656 Reduced 51.16%
63,632 $465,000
Q2 2023

Aug 08, 2023

BUY
$8.29 - $11.16 $28,409 - $38,245
3,427 Added 2.7%
130,288 $1.36 Million
Q1 2023

May 11, 2023

BUY
$9.1 - $15.48 $58,986 - $100,341
6,482 Added 5.38%
126,861 $1.31 Million
Q4 2022

Feb 14, 2023

BUY
$12.06 - $21.55 $90,474 - $161,668
7,502 Added 6.65%
120,379 $1.66 Million
Q3 2022

Nov 10, 2022

BUY
$19.54 - $24.3 $99,106 - $123,249
5,072 Added 4.7%
112,877 $2.31 Million
Q2 2022

Aug 11, 2022

BUY
$17.83 - $24.49 $49,157 - $67,518
2,757 Added 2.62%
107,805 $2.09 Million
Q1 2022

May 12, 2022

SELL
$20.46 - $29.16 $16,756 - $23,882
-819 Reduced 0.77%
105,048 $2.26 Million
Q4 2021

Feb 10, 2022

SELL
$24.35 - $30.97 $95,719 - $121,743
-3,931 Reduced 3.58%
105,867 $2.92 Million
Q3 2021

Nov 12, 2021

SELL
$23.36 - $29.2 $334,818 - $418,523
-14,333 Reduced 11.55%
109,798 $2.85 Million
Q2 2021

Aug 05, 2021

SELL
$22.39 - $28.07 $148,714 - $186,440
-6,642 Reduced 5.08%
124,131 $3.37 Million
Q1 2021

May 06, 2021

BUY
$15.44 - $23.4 $2,856 - $4,329
185 Added 0.14%
130,773 $3.06 Million
Q4 2020

Feb 10, 2021

BUY
$10.34 - $15.33 $137,005 - $203,122
13,250 Added 11.29%
130,588 $2 Million
Q3 2020

Nov 12, 2020

SELL
$8.26 - $12.74 $58,009 - $89,473
-7,023 Reduced 5.65%
117,338 $1.42 Million
Q2 2020

Aug 13, 2020

SELL
$9.05 - $12.01 $64,979 - $86,231
-7,180 Reduced 5.46%
124,361 $1.27 Million
Q1 2020

May 06, 2020

BUY
$8.33 - $16.9 $24,615 - $49,939
2,955 Added 2.3%
131,541 $1.37 Million
Q4 2019

Feb 05, 2020

BUY
$14.23 - $18.16 $102,555 - $130,879
7,207 Added 5.94%
128,586 $2.06 Million
Q3 2019

Oct 23, 2019

BUY
$17.78 - $21.89 $143,840 - $177,090
8,090 Added 7.14%
121,379 $2.24 Million
Q2 2019

Aug 14, 2019

BUY
$18.78 - $25.01 $59,157 - $78,781
3,150 Added 2.86%
113,289 $2.23 Million
Q1 2019

May 01, 2019

BUY
$19.43 - $23.46 $36,567 - $44,151
1,882 Added 1.74%
110,139 $2.52 Million
Q4 2018

Jan 31, 2019

BUY
$18.9 - $22.06 $396,484 - $462,774
20,978 Added 24.04%
108,257 $2.18 Million
Q3 2018

Nov 07, 2018

SELL
$18.95 - $24.23 $10,593 - $13,544
-559 Reduced 0.64%
87,279 $1.9 Million
Q2 2018

Aug 06, 2018

BUY
$17.42 - $23.0 $35,902 - $47,403
2,061 Added 2.4%
87,838 $1.95 Million
Q1 2018

May 02, 2018

BUY
$15.71 - $17.7 $16,762 - $18,885
1,067 Added 1.26%
85,777 $1.48 Million
Q4 2017

Feb 09, 2018

BUY
$16.56 - $17.8 $196,070 - $210,752
11,840 Added 16.25%
84,710 $1.41 Million
Q3 2017

Nov 06, 2017

BUY
$16.09 - $18.76 $1.17 Million - $1.37 Million
72,870
72,870 $1.25 Million

Others Institutions Holding ANGO

About ANGIODYNAMICS INC


  • Ticker ANGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 39,107,800
  • Market Cap $280M
  • Description
  • AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation syst...
More about ANGO
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.